HighBeam QuickSearch
Get direct access to articles and research when you
add HighBeam to your browser's search toolbar.
|
-
-
KGA Upgrades BB BIOTECH AG to BUY.
-
TFN/Nelson's Research Reports; Mar 24, 2009; 288 Words
...Nelson's Broker Summaries via COMTEX) -- Company: BB BIOTECH AG Report Date: March 20, 2009 Report Headline: "BB Biotech (Buy Upgrade from Hold) - Results for Q4. Inline...
-
-
BB Biotech AG (BION.S) Weekly Earnings Information.
-
TFN/Nelson's Foreign Earnings Reports; Mar 7, 2009; 327 Words
Mar 07, 2009 (Thomson Financial via COMTEX) -- Company: BB Biotech AG (BION.S) Country: Switzerland Actual EPS for FY End (12/2008): 11.72 Current FY High EPS Estimate: 12.33 Current...
-
-
BB BIOTECH AG Consensus Recommendation: STRONG BUY.
-
TFN/Nelson's Research Reports; Mar 24, 2009; 300 Words
Mar 24, 2009 (Nelson's Broker Summaries via COMTEX) -- Company: BB BIOTECH AG Consensus Recommendation: STRONG BUY (Strong Buy: 1, Buy: 0, Hold: 0, Underperform: 0, Sell: 0) Quarter Consensus Estimate...
-
-
Swiss BB Biotech appoints new management team members.
-
ADP News Switzerland; Sep 22, 2009; 369 Words
...2009 - Swiss investment company BB Biotech AG (SWF:BION) announced on Tuesday...Kosar and Koller have been on the biotech team of Bellevue Asset Management, the designated management company of BB Biotech, since 2004. The previous team...
-
-
BB Medtech AG Makes $12 Million Investment In Israeli Biotech Company.
-
Israel Business Today; Sep 15, 1998; 591 Words
BB Medtech a part of Swiss Bellevue asset management group, which manages over...made a $12 million investment in Combact Diagnostic Systems. The Israeli biotech company is developing a process to automatically detect bacteria in urine...
-
-
Baltimore appointed to board of directors at biotech company.
-
Biotech Week; Sep 10, 2003; 608 Words
...experience on the boards of directors for Amgen, Inc., and BB Biotech AG, a long-time MedImmune shareholder. We look forward...on the MedImmune board. This article was prepared by Biotech Week editors from staff and other reports.
-
-
Sangui BioTech International Inc.: Wholly Owned German Subsidiary GlukoMediTech AG Has Developed A New Line of Products For Non-Invasive Cardiorespiratory Monitoring.
-
Business Wire; Nov 3, 1999; 700+ Words
...Subsidiary GlukoMediTech AG Has Developed A New Line...Sleep Diagnostics Sangui BioTech International Inc. (Nasdaq BB: SGBI) reported today...subsidiary GlukoMediTech AG, Witten has developed...Jorg Alte - Sangui BioTech International Inc...
-
-
New Jersey Pharmaceutical Firm Completes $25 Million Private Placement.
-
Knight Ridder/Tribune Business News; Nov 12, 1998; ; 700+ Words
...placement of 1 million shares to Biotech Target S.A., a subsidiary of BB Biotech AG, based in Schaffhausen, Switzerland...chief administrative officer. Biotech also received a warrant from...Asset Management, managers of BB Biotech. Algos' products...
-
-
GERMANY'S NEUER MARKT CLOSING AMID MOUNTING LOSSES, SCANDALS.(Brief Article)
-
BIOWORLD Today; Sep 30, 2002; ; 700+ Words
MUNICH, Germany - Deutsche Boerse AG, the company that operates Germany's most...companies listed on the Neuer Markt. Larger biotech companies listed on the market, such as BB Biotech AG, of Schaffhausen, Switzerland (market cap...
-
-
Germany's Neuer Markt Closing Amid Mounting Losses, Scandals.
-
BIOWORLD Today; Nov 4, 2009; 700+ Words
...Correspondent MUNICH, Germany - Deutsche Boerse AG, the company that operates Germany's most...companies listed on the Neuer Markt. Larger biotech companies listed on the market, such as BB Biotech AG, of Schaffhausen, Switzerland (market cap...
-
-
ALGOS PLACEMENT RAISES $25M FOR PAIN TREATMENT By Jim Shrine Special To BioWorld Today.
-
BIOWORLD Today; Nov 11, 1998; 700+ Words
...company sold 1 million shares at $25 each to Biotech Target SA, a subsidiary of BB Biotech AG, of Schaffhausen, Switzerland. The price...now has about 17 million shares outstanding. Biotech Target also received a warrant for the purchase...
-
-
VIROLOGIC NETS $12.6M TO PUSH HIV DRUG SUSCEPTIBILITY ASSAY.
-
BIOWORLD Today; Aug 31, 1998; 700+ Words
...marketing this year. Participating in the financing were BB Biotech AG, of Schaffhausen, Switzerland; Capital Management...Angeles; and Soros Fund Management, of New York. BB Biotech is a new investor. *
-
-
Probiodrug Gets [euro]36M for Novel Alzheimer's Program.
-
BIOWORLD Today; Apr 23, 2009; 700+ Words
...biotechnology this year, Probiodrug AG took in more than C36 million (US...acquired Munich, Germany-based Ingenium AG in 2007. "Since it's a new approach...The funding round was co-led by BB Biotech AG, of Zurich, Switzerland, and Paris...
-
-
The Medicines Company Completes $36 Million Private Placement With Morgan Stanley Venture As Lead Investor
-
PR Newswire; Aug 31, 1998; 700+ Words
...investor for this round of financing. In addition, E.M. Warburg, Pincus & Co. Inc. and Biotech Growth S.A., a subsidiary of BB Biotech AG, the Company's two largest shareholders, purchased 36% of the new shares issued. Other new...
-
-
Dow Jones Indexes Announces Changes in the Composition of Country Blue Chip Indexes, Changes Are a Result of an Annual Review of the Dow Jones Country Titans Indexes.
-
PrimeZone Media Network; Mar 3, 2005; 700+ Words
...Dow Jones Actelion Ltd. Kudelski S.A. Switzerland Unaxis Holding AG BB Biotech AG Titans 30 --------------------...
-
-
THE MEDICINES CO. RAISES $36M FOR HIRULOG, MIGRAINE TREATMENT.
-
BIOWORLD Today; Sep 1, 1998; 700+ Words
...participated in this round are E.M. Warburg, Pincus & Co. Inc., of New York; Biotech Growth SA, of Zug, Switzerland, a subsidiary of BB Biotech AG, of Schaffhausen, Switzerland; and Hanseatic Corp., of New York. The first two companies...
-
-
Eyetech Pharmaceuticals, Inc. Announces Appointment of Phillip M. Satow to the Board of Directors and Resignation of Michael G. Mullen from the Board.
-
PR Newswire; Jun 15, 2004; 700+ Words
...Laboratories and Crucell, Inc., a publicly-traded biotech company. Mr. Satow previously spent 14 years at Pfizer...related entity is the asset manager for the portfolios of BB Biotech AG, which remains a significant Eyetech stockholder. For...
-
-
ViroLogic Announces $12.6 Million In Private Financing
-
PR Newswire; Aug 26, 1998; 700+ Words
...raising $12.6 million. Firms contributing to the preferred equity financing include new investor, Biotech Growth S.A. a subsidiary of BB Biotech AG, and current shareholders The Capital Group and Soros Fund Management. ViroLogic is developing...
-
-
Germany Neuer Markt closing amid mounting losses, scandals.
-
Medical Device Daily; Oct 1, 2002; 700+ Words
...s value, more than 170,000 jobs are tied to companies listed on the Neuer Markt. Larger biotech companies listed on the market, such as BB Biotech AG (Schaffhausen, Switzerland) or Qiagen (Hilden, Germany), are likely to be part of the...
-
-
MedImmune Announces Addition of David Baltimore, Ph.D. To Board of Directors.
-
PR Newswire; Aug 14, 2003; 700+ Words
...contribute to the business of biotechnology through his experience on the boards of directors for Amgen, Inc. and BB Biotech AG, a long-time MedImmune shareholder. We look forward to Dr. Baltimore's contribution to our board from his vantage...
|
|